Letter in response to “Our HER2 is same as yours”

by Matsusaka, Satoshi, Yoshida, Kazuhiro
Published in Transl Gastroenterol Hepatol (2016)

Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab

by Osumi, Hiroki, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Published in Onco Targets Ther (2015)

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

by Sato, Yasuyoshi, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Published in Onco Targets Ther (2015)

Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer

by Ohhara, Yoshihito, Suenaga, Mitsukuni, Matsusaka, Satoshi, Shinozaki, Eiji, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Published in Onco Targets Ther (2015)

Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

by OSUMI, HIROKI, MATSUSAKA, SATOSHI, WAKATSUKI, TAKERU, SUENAGA, MITSUKUNI, SHINOZAKI, EIIJ, MIZUNUMA, NOBUYUKI
Published in Mol Clin Oncol (2015)

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

by Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Yamaguchi, Toshiharu
Published in Drug Des Devel Ther (2015)

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

by SUZUKI, SHUN-ICHI, MATSUSAKA, SATOSHI, HIRAI, MITSUHARU, SHIBATA, HARUMI, TAKAGI, KOICHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Published in Int J Oncol (2015)

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

by Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Shinozaki, Eiji, Matsusaka, Satoshi, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Published in Onco Targets Ther (2015)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

by Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Published in Drug Des Devel Ther (2015)

Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report

by Osumi, Hiroki, Matsusaka, Satoshi, Shinozaki, Eiji, Suenaga, Mitsukuni, Mingyon, Mun, Saiura, Akio, Ueno, Masashi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Published 2013

Secondary central nervous system lymphoma surrounding a region injured by subarachnoid hemorrhage and subsequent aneurysmal clipping

by Murata, Yoriko, Hata, Yasuhiro, Noda, Yoshihiro, Matsusaka, Satoshi, Fukui, Naoki, Kadota, Tomohito, Iwata, Jun, Machida, Takuya, Yamagami, Takuji
Published in Biomed Rep (2017)

Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of...

by OBA, MASARU, CHIN, KEISHO, KAWAZOE, YOSHIMASA, TAKAGI, KOICHI, OGURA, MARIKO, SHINOZAKI, EIJI, SUENAGA, MITSUKUNI, MATSUSAKA, SATOSHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Published 2011

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

by OBA, MASARU, CHIN, KEISHO, KAWAZOE, YOSHIMASA, TAKAGI, KOICHI, OGURA, MARIKO, SHINOZAKI, EIJI, SUENAGA, MITSUKUNI, MATSUSAKA, SATOSHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Published 2011

Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

by KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Published 2011

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chem...

by Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Kumekawa, Yosuke, Ogura, Mariko, Ozaka, Masato, Matsusaka, Satoshi, Chin, Keisho, Yamamoto, Noriko, Mizunuma, Nobuyuki
Published in BMC Cancer (2015)

Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy

by Matsusaka, Satoshi, Kobunai, Takashi, Yamamoto, Noriko, Chin, Keisho, Ogura, Mariko, Tanaka, Gotaro, Matsuoka, Kazuaki, Ishikawa, Yuichi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Published in Genes Cancer (2016)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)

by Suenaga, Mitsukuni, Fujimoto, Yoshiya, Matsusaka, Satoshi, Shinozaki, Eiji, Akiyoshi, Takashi, Nagayama, Satoshi, Fukunaga, Yosuke, Oya, Masatoshi, Ueno, Masashi, Mizunuma, Nobuyuki, Yamaguchi, Toshiharu
Published in Onco Targets Ther (2015)

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

by Suenaga, Mitsukuni, Mashima, Tetsuo, Kawata, Naomi, Wakatsuki, Takeru, Horiike, Yuki, Matsusaka, Satoshi, Dan, Shingo, Shinozaki, Eiji, Seimiya, Hiroyuki, Mizunuma, Nobuyuki, Yamaguchi, Kensei, Yamaguchi, Toshiharu
Published in Oncotarget (2016)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

by Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Published in Pharmacogenomics J (2015)

Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer

by Suenaga, Mitsukuni, Cao, Shu, Zhang, Wu, Matsusaka, Satoshi, Okazaki, Satoshi, Berger, Martin D., Miyamoto, Yuji, Schirripa, Marta, Barzi, Afsaneh, Yamamoto, Noriko, Yamaguchi, Toshiharu, Lenz, Heinz-Josef
Published in Pharmacogenet Genomics (2021)